Volume : 12, Issue : 01, January – 2025
Title:
QBD APPROACH TO RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE ESTIMATION OF IVABRADINE FOR API AND PHARMACEUTICAL FORMULATION
Authors :
Ms. Vrushali V. Shelar*, Dr. Kamble H.V, Mr. Sugriv R. Ghodake, Dr. Santosh Waghmare
Abstract :
The development and validation of a robust analytical method for Ivabradine estimation in APIs and pharmaceutical formulations are critical to ensuring drug quality and therapeutic efficacy. This study adopts a Quality by Design (QbD) approach to optimize and validate an RP-HPLC method for this purpose. Central Composite Design (CCD) was employed to evaluate the impact of key chromatographic parameters, including mobile phase composition and pH. A total of 13 experimental runs were conducted, and the optimal conditions were identified as a mobile phase consisting of methanol, acetonitrile, and phosphate buffer (35:35:30 v/v) at pH 4.0, using a C18 column. The method demonstrated high precision, accuracy, and robustness, with satisfactory retention times, asymmetry factors, and theoretical plate counts. Validation was performed per ICH guidelines, confirming the method’s applicability for routine quality control and stability testing. This QbD-driven approach ensures compliance with regulatory standards while offering a reliable framework for analytical method development.
Keywords: Quality by Design (QbD), RP-HPLC, Ivabradine, Analytical Method Validation, Central Composite Design (CCD), Chromatographic Optimization etc.
Cite This Article:
Please cite this article in press Vrushali V. Shelar et al., QBD Approach To Rp-Hplc Method Development And Validation For The Estimation Of Ivabradine For Api And Pharmaceutical Formulation.,Indo Am. J. P. Sci, 2025; 12 (01).
Number of Downloads : 10
References:
1. International Council for Harmonisation (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R1). ICH Harmonised Guideline; 2005.
2. FDA. Guidance for Industry: QbD for Analytical Method Development. U.S. Food and Drug Administration; 2011.
3. Patel DB, Patel NJ, Prajapati AM, Patel SA. A comprehensive review on Quality by Design (QbD) in analytical method development. Int J Pharm Sci Rev Res. 2018;51(1):7-14.
4. Goyal A, Yusuf S. The effect of Ivabradine on cardiovascular outcomes in chronic heart failure: A meta-analysis. Eur Heart J. 2017;38(5):341-7. doi:10.1093/eurheartj/ehw001.
5. Sahu PK, Ramisetti NR, Cecchi T, Swain S, Patro CS, Panda J. An overview of experimental designs in HPLC method development and validation. J Pharm Biomed Anal. 2018; 147:590-611.
6. Desai D, Patel D, Shrivastav P. Application of Quality by Design in RP-HPLC method development for pharmaceuticals. J Chromatogr Sci. 2020;58(5):381-9.
7. European Medicines Agency (EMA). Guideline on Bioanalytical Method Validation. EMA/CHMP/EWP/192217/2009. https://www.ema.europa.eu/
8. Soni LK, Verma A, Singh N, Parmar SC. Quality by Design (QbD) approaches in pharmaceutical development: An overview. Int J Pharm Pharm Sci. 2020;12(4):15-23.
9. Jayakumar C, Shobana S, Krishnan M, Suriyaprakash TN. Analytical method development and validation for estimation of Ivabradine hydrochloride by RP-HPLC method. Int J ChemTech Res. 2019;12(1):225-31.
10. Costa FO, Sousa JJ, Pais AA. Formulation-driven QbD in analytical development: RP-HPLC method for hydrophilic and lipophilic drugs. J Chromatogr B. 2018; 1090:75-82. doi: 10.1016/j.jchromb.2018.06.012.
11. Shweta Maheshwari, Amit P. Khandar and Anurekha Jain. Quantitative Determination and Validation of Ivabradine HCL by Stability Indicating RP- HPLC Method and Spectrophotometric Method in Solid Dosage Form. Eur J Anal Chem 2010; 5(1): 53–62.
12. Prajakta Gopinath Thete, Ravindranath Bhanudas Saudagar. Analytical Method Development and Validation for the Determination of Ivabradine HCl by RP- HPLC in bulk and Pharmaceutical Dosage form. Asian J Pharm Tech 2019; 9(2): 89- 92.
13. Pooja A. Patil, Hasumati A. Raj, Gautam B. Sonara. Q-Absorbance Ratio Spectrophotometric method for simultaneous determination of Atenolol and Ivabradine HCl in synthetic mixture. Asian J Res Pharm Sci 2016; 6(1): 27-33.
14. Pooja A. Patil, Dr. Hasumati A. Raj and Dr. Gautam B. Sonara. Simultaneous Estimation of Atenolol and Ivabradine HCl using UVSpectrophotometry. Asian J Pharm Anal 2016; 6(2): 109-114.
15. Sethi P.D. (1997). Quantitative Analysis of drugs in Pharmaceutical Formulations. 3rd ed. CBS publishers and distributors, New Delhi, pp. 17-19.
16. J. Bassett, R. C. Denney, G.H. Jeffery and J. Mendham. (1978). Vogel’s Text Book of Quantitative Inorganic Analysis. 4th ed. Longman Group Ltd: England, pp. 1- 9.
17. Masoom, R. Zeid, A. AlOthman, a. Nafisur, R. (2013). Analytical techniques in pharmaceutical analysis: A review, Arabian Journal of Chemistry, pp. 1878- 5352.
18. Panchumarthy, R., Naga, N. Pravallika, D. Navya, S. (2015). A Review on Step- by-Step Analytical Method Validation, IOSR Journal of Pharmacy, 5(10). pp. 07- 19.
19. Skoog D., Holler, J., Crouch, S., (2007). Principles of Instrumental Analysis. 6th ed. Belmont, CA: Thomson Brooks/Cole, pp. 169–173.
20. Mendham, J., Denney, R.C., Barnes, J.D., Thomas, M.J. Vogel’s Textbook of Quantitative Chemical Analysis. 6th ed. Publication of Pearson Education; pp. 172- 173, 301-308.
21. Christian, G., (2003). Analytical Chemistry. 6th ed. Publication of John Wiley and Sons, pp.1-15, 92-114, 126-132, 604-619.
22. Sharma, B.K., (2002). Instrumental Methods of Chemical Analysis. 25th ed. Goel Publication Co.; Meerut, pp.3, 6.
23. Chatwal, G.R., Anand S.K., (2007). Instrumental Methods of Chemical Analysis. 5th ed. Himalaya Publishing House; Delhi, pp.2.150, 2.566-2.585, 2.624-2.630.
24. Sharma, Y.R., (1991). Introduction of Organic Spectroscopy. 4th ed CBS Publishers and Distributors; New Delhi. pp.5-25.
25. Beckett A.H., Stenlake J.B., (2004). Practical Pharmaceutical Chemistry. 4th ed. Part 2. Publication of New Delhi, pp.275-300.
26. Lampman, Pavia. Kriz, Vyvyan., Spectroscopy. 4th ed. Cengage Learning. pp. 379-406.
27. P. S. Kalsi., Spectroscopy of organic compounds. 6th ed. New age International publisher. pp. 9-54.
28. International Conference on Hormonization (ICH) of Technical Requirements for the Registration of Pharmaceuticals for Human Use, Validation of Analytical Procedure: Text and Methodology {ICH- Q2 (R1)}; November 2015: 1-13
29. Bauer LC, Santana DD, Macedo MD, Torres AG, Souza NE, Simionato JI. Method validation for simultaneous determination of cholesterol and cholesterol oxides in milk by RP-HPLC-DAD. J Braz Chem Soc, 2014; 25(1):161–8.
30. Cui XY, Shi XJ, Li ZD, Zhong MK. Determination of ivabradine in rat plasma by a validated HPLC with fluorescence detection. Chinese Pharm J, 2010; 4:024.
31. Deodhe ST, Dhabarde DM, Kamble MA, Mahapatra DK. Novel stability indicating RP-HPLC method for the estimation of Pinaverium bromide in tablet formulation: assay development and validation. Eur J Anal Chem, 2017a; 12(2):3– 16.
32. Deodhe ST, Dhabarde DM, Kamble MA, Mahapatra DK. Development and validation of a novel stability indicating RP-HPLC method for the estimation of Entecavir in tablet formulation. Eur J Anal Chem, 2017b; 12(3):223–35.
33. DiFrancesco D, Camm JA. Heart rate lowering by specific and selective I f current inhibition with ivabradine. Drugs, 2004; 64(16):1757–65.
34. Gokhroo RK, Priti K, Ranwa BL, Anantharaj A, Kishor K, Pandey S, Roy R. Comparison of ivabradine and metoprolol in patients with acute inferior wall myocardial infarction: expanding arena for ivabradine. J Am Coll Cardiol, 2016; 67(13S):535.
35. Jha SK, Bhaskaran S, Kamble MA, Mahapatra DK. A novel RPHPLC based assay for the estimation of tramadol HCl content in tablets: development and validation. Inventi Impact Pharm Anal Qual Assur, 2017; 2017(4):142–6.
36. Kaski JC, Gloekler S, Ferrari R, Fox K, Lévy BI, Komajda M, Vardas P, Camici PG. Role of ivabradine in management of stable angina in patients with different clinical profiles. Open Heart 2018; 5(1):e000725.
37. Li N, Shi XJ, Zhang ZL, Zhong MK. Determination of ivabradine and its active metabolite N-desmethylivabradine in rat plasma by HPLC and their pharmacokinetic study. Chinese Pharm J, 2011; 15:019.
38. Maheshwari S, Khandhar AP, Jain A. Quantitative determination and validation of ivabradine HCl by stability indicating RP-HPLC method and spectrophotometric method in solid dosage form. Eur J Anal Chem, 2010; 5(1):53– 62.
39. Mostafa NM, Fayez YM, Farid JF, Abd El-Alim AE. Stability indicating spectrophotometric methods for determination of ivabradine hydrochloride in the presence of its degradation product. Anal Chem Lett, 2017; 7(2):280–94.
40. Patra S, Panda S. Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of ivabradine controlled-release formulations. Pharma Tutor, 2014; 2(8):201–13.
41. Perumal SS, Ekambaram SP, Raja S. Analytical method development and validation of simultaneous estimation of rabeprazole, pantoprazole, and itopride by reverse-phase high-performance liquid chromatography. J Food Drug Anal, 2014; 22(4):520–6.
42. Prakash O, Mahapatra DK, Singh R, Singh N, Verma N, Ved A. Development of a new isolation technique and validated RP-HPLC method for Quercetin and Kaempferol from Azadirachta indica leaves. Asian J Pharm Anal, 2018; 8(3):164– 8.
43. Ptaszynski P, Kaczmarek K, Ruta J, Klingenheben T, Cygankiewicz I, Wranicz JK. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Therapeut, 2013; 18(4):338–44.
44. Ranjha NM, Majeed A, Hussain I, Fawad Rasool M. Quantitative determination and validation of ivabradine-HCl in pharmaceutical formulation and rabbit plasma by high performance liquid chromatography method. Curr Pharm Anal, 2017; 13(5):446–51.
45. Rehman M, Nagamallika G. Validated rp-hplc method for the determination of ivabradine hydrochloride in pharmaceutical formulation. Int J Pharm Sci Drug Res, 2017; 9(5):228–33.
46. Sawale V, Dhabarde DM, Mahapatra DK. Development and validation of UV spectrophotometric method for simultaneous estimation of olmesartan medoxomil and chlorthalidone in bulk and tablet. Eur J Anal Chem, 2017; 12(1):55–66.
47. Seerapu S, Srinivasan BP. Development and validation of RPHPLC method for the estimation of ivabradine hydrochloride in tablets. Indian J Pharm Sci, 2010; 72(5):667–71.
48. B. P. Srinivasan and Sunitha Seerapu. Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets. Indian Journal of Pharmaceutical Sciences. 2010; 72(5): 667–671.
49. Selva Kumar P., Pandiyan K., Rajagopal K. Development and validation of stability indicating rapid HPLC method for the estimation of Ivabradine Hydrochloride in solid oral dosage forms. International Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6(4): 378-382.
50. Sagarika Panda and Srikanta Patra. Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of ivabradine controlled-release formulations. PharmaTutor. 2014; 2(8); 201-213.
51. Shweta Maheshwari, Amit P. Khandar and Anurekha Jain. Quantitative Determination and Validation of Ivabradine HCL by Stability Indicating RP- HPLC Method and Spectrophotometric Method in Solid Dosage Form. Eurasian J Anal Chem. 2010; 5(1): 53–62.
52. Prajakta Gopinath Thete, Ravindranath Bhanudas Saudagar. Analytical Method Development and Validation for the Determination of Ivabradine HCl by RP- HPLC in bulk and Pharmaceutical Dosage form. Asian Journal of Pharmacy and Technology. 2019; 9(2): 89-92.
53. Pooja A. Patil, Hasumati A. Raj, Gautam B. Sonara. Q-Absorbance Ratio Spectrophotometric method for simultaneous determination of Atenolol and Ivabradine HCl in synthetic mixture. Asian Journal of Research in Pharmaceutical Sciences. 2016; 6(1): 27-33.
54. Pooja A. Patil, Dr. Hasumati A. Raj and Dr. Gautam B. Sonara. Simultaneous Estimation of Atenolol and Ivabradine HCl using UV-Spectrophotometry. Asian Journal of Pharmaceutical Analysis. 2016; 6(2): 109-114.
55. Sun W, Chen R, Li W, Zhang H, Ye J, Cui X, Huang C. Simultaneous determination of ivabradine, metoprolol and their metabolites in rat plasma by ultra-performance liquid chromatography tandem mass spectrometry and its application in a pharmacokinetic study. Anal Method, 2015; 7(19):8459–65.
56. Volterrani M, Iellamo F. Complementary and synergic role of combined beta- blockers and ivabradine in patients with chronic heart failure and depressed systolic function: a new therapeutic option? Cardiac Failure Rev, 2016; 2(2):130.
57. Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, MüllerWerdan U; ADDITIONS Study Investigators. Ivabradine in combination with metoprolol improves symptoms and quality of life in patients with stable angina pectoris: a post hoc analysis from the ADDITIONS trial. Cardiology, 2016; 133(2):83–90.
58. Zarifis J, Kallistratos M, Katsivas A, investigators of the Prospective, Non- interventional, Observational Study of the Antianginal Efficacy of Ivabradine During a 4-Month Treatment of a Greek Population with Coronary Artery Disease. Antianginal efficacy of ivabradine/ metoprolol combination in patients with stable angina. Clin Cardiol, 2016; 39(12):697–702.
59. G. Vidya sagar. (2012). Instrumental method of drug analysis. Pharma med press editor. pp.106.
60. The Merck Index, (2006). Merck & Co. Inc. 14th ed. White house station. NJ. pp. 4781, 491, 4935, 6528.
61. Sethi. PD. (2001). HPLC Quantitative analysis of pharmaceutical formulations, 1st ed. CBS Publishers and distributors. New Delhi. pp 94-105.
62. Glajch. L., Kirkal. J., and Snyder R., (1999). Practical HPLC method development. 2nd ed. John Wiley and sons. INC. New York. pp 234-260.
63. Sethi, P.D. (2001). HPLC- High Performance Liquid Chromatography- Quantitative Analysis of Pharmaceutical Formulations. 1st ed. CBS Publishers and Distributors. New Delhi. pp.3-72, 116-120.
64. Daniel A Jones, Adam Timmis and Andrew Wragg. Novel drugs for treating angina. Br Med J 2013; 347: f4726.
65. Ivabradine. https://www.drugbank.ca/drugs/DB09083 (Assessed on 16 December 2018).
66. Md. Rezowanur Rahman, Md. Asaduzzaman and Ashraf Islam. Development and validation of RP-HPLC method for analysis of ivabradine hydrochloride in tablet dosage forms. Res J Pharm Biol Chem Sci. 2011; 3(3): 1032-1043.
67. B. P. Srinivasan and Sunitha Seerapu. Development and Validation of RP-HPLC Method for the Estimation of Ivabradine Hydrochloride in Tablets. Ind J Pharm Sci 2010; 72(5): 667–671.
68. Selva Kumar P., Pandiyan K., Rajagopal K. Development and validation of stability indicating rapid HPLC method for the estimation of Ivabradine Hydrochloride in solid oral dosage forms. Int J Pharm Pharm Sci 2014; 6(4): 378- 382.
69. Sagarika Panda and Srikanta Patra. Rapid and selective UV spectrophotometric and RP-HPLC methods for dissolution studies of ivabradine controlled-release formulations. PharmaTutor 2014; 2(8); 201-213.
70. Satinder, A., Michael, D., (2009). Handbook of pharmaceutical analysis by HPLC Series, editor. separation sciences and technology. Elsevier. p. 3-5, 8, 35, 43, 62, 97, 125, 146-166, 197.